Buddy you mentioned this few times and I noticed it but the doctor who were trained and participated in the trial has not used it so far as revenue so far was from NZ... IMO.
Australia special access scheme is different to EUA given by FDA so chances are low for people to be aware of the product... IMO.
OSL had plenty of cash and time to market and establish product in EU but so far they have not achieved anything (i e. zero sell).. IMO.
let's hope come out clean and explain why no sell is achieved in EU/UK.. imo.
OSL Price at posting:
4.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)